Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01327612
Title Open Label Extension Study of Conatumumab and AMG 479
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Amgen
Indications

colorectal cancer

sarcoma

lymphoma

Advanced Solid Tumor

lung non-small cell carcinoma

Therapies

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Ganitumab

Bevacizumab

Conatumumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.